The Truth Emerges On July 29, 2025, Novo issued a press release and held a conference call lowering its sales and profit outlook for 2025, citing "lowered growth expectations for the second half of 2025" for both Wegovy and Ozempic due to "the persistent use of compounded GLP-1s, slower-than-expected market expansion and competition." Management also noted that despite the expiry of the FDA grace period for mass compounding on May 22, 2025, company research showed that unsafe and unlawful mass compounding continued
[DOI] [PubMed] [Google Scholar] 64.Araj S.K., Szeleszczuk
Clinical trials show tirzepatide produces 15-22% body weight reduction versus 10-18% with semaglutide over similar timeframes
Not officially approved for weight loss, but can be prescribed off-label if medically appropriate
Oprahs willingness to discuss her journey fosters a sense of community and support for individuals who are struggling with their weight
Pulmonary Aspiration During General Anesthesia or Deep Sedation Inform patients that BYDUREON BCISE may cause their stomach to empty more slowly which may lead to complications with anesthesia or deep sedation during planned surgeries or procedures
